 | | Vol. 14.36 – 22 September, 2023 |
| |
|
|
| Scientists targeted immunometabolic mechanisms of PI3Ki resistance, with the goal of durable tumor control in aggressive-variant prostate cancer.
[Clinical Cancer Research] |
|
|
|
 | | PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| The authors demonstrated that the expression level of phosphatase and tensin homolog (PTEN) was inversely correlated with the signature score of unfolded protein response in prostate cancer.
[Cellular and Molecular Life Sciences] |
|
|
|
| Researchers developed an RNA interference method against adenosine triphosphate (ATP) by constructing an interfering plasmid-expressing ATP-binding RNA aptamer, which notably inhibited the growth of prostate cancer cells through diminishing the availability of cytoplasmic ATP.
[Molecular Pharmaceutics] |
|
|
|
| The authors evaluated the therapeutic effect of selenium in combination with a tomato extract in aged rats with benign prostatic hyperplasia (BPH).
[Journal of Cellular and Molecular Medicine] |
|
|
|
| Scientists elucidated the effects of acupuncture on the protein and gene expression of estrogen receptors alpha and beta in testosterone-induced benign prostatic hyperplasia in rat models.
[Journal of Steroid Biochemistry and Molecular Biology] |
|
|
|
| Experiments in vitro showed that DTX-loaded poly-Tetraethylene glycol nanoparticles had good compatibility to healthy cells and strong anti-tumor effect.
[Journal Of Materials Science-Materials In Medicine] |
|
|
|
| Investigators elucidated the effects of senescence induction on proliferation, cell cycle, and apoptosis in prostate cancer stem cells (CSCs) and non-CSCs.
[Biochemical and Biophysical Research Communications] |
|
|
|
| Using CRPC cell lines, the transwell chamber experiments revealed ataxia telangiectasia mutant kinase (ATM) promoted macrophage recruitment in CRPC cells in vitro via C-X-C motif chemokine ligand 12.
[Immunological Investigations] |
|
|
|
| Researchers aimed to clarify the regulatory roles of the SOX2/Notch axis in CRPC. They conducted immunohistochemistry analyses to evaluate SOX2, Notch, and Hey1 expression in the prostate cancer and CRPC tissues.
[Molecular Biology Reports] |
|
|
|
|
| Scientists provide a summary of the status of immunotherapy in treating prostate cancer, with a discussion of multiple immune modalities, including vaccines, adoptively transferred T cells, and bispecific T cell engagers.
[Cell Reports Medicine] |
|
|
|
| Investigators summarize and outline the clinical and pathological features, differential diagnosis, molecular aspects, and management of intraductal carcinoma of the prostate, as described in previous studies.
[International Journal Of Urology] |
|
|
|
|
| Two renowned biomedical researchers have been awarded £1 million to undertake world-leading research into diseases such as prostate cancer and mitochondrial disease at Northumbria University.
[Northumbria University] |
|
|
|
|
| October 29 – November 1, 2023
New York, New York, United States |
|
|
|
|
|
| | Cedars-Sinai – Los Angeles, California, United States |
|
|
|
| | Massachusetts General Hospital – Boston, Massachusetts, United States |
|
|
|
| | Houston Methodist Research Institute – Houston, Texas, United States |
|
|
|
| | The Sidney Kimmel Cancer Center – Philadelphia, Pennsylvania, United States |
|
|
|
| | Cedars-Sinai – Los Angeles, California, United States |
|
|
|
|
Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
